FDA’s Generative AI Medical Device Rulebook Faces Pushback as Comment Window Nears Close
A discussion paper from the FDA's Digital Health Center of Excellence on regulating generative AI medical devices is drawing detailed objections from hospital groups before its public comment window closes October 19, with disputes centering on premarket review and postmarket monitoring.